A COVID-19 vaccine made in Taiwan by Medigen Vaccine Biologics Corp. has received emergency use authorization (EUA) in Paraguay after the unblinding of a Phase 3 clinical trial conducted in the South American country, the company said in a statement Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Taiwan to see nine extended holidays in 2026
06/13/2025 09:09 PM - Cross-Strait
200 march in Taipei to mark 2019 Hong Kong protest, warn against China
06/13/2025 08:30 PM - Business
'Taiwan Pass' prices to soar on train fare hikes
06/13/2025 07:50 PM - Society
Student killed by falling tree at Taichung's Feng Chia University
06/13/2025 07:20 PM - Society
6 hospitalized with severe burns in Taoyuan gas explosion
06/13/2025 06:11 PM